OBJECTIVES: To identify predictors for the discrimination of @entity1419 (IMCC) and @entity157 ( @entity157 ) from @entity157 ( @entity157 ) for primary @entity96 on @entity18497 -enhanced MRI among high-risk @entity409 ( @entity409 ) @entity1 using classification tree analysis (CTA). METHODS: A total of 152 @entity1 with histopathologically proven IMCC (n   =   40), @entity157 (n   =   24) and @entity157 (n   =   91) were enrolled. Tumour marker and MRI variables including morphologic features, signal intensity, and enhancement pattern were used to identify @entity5 suspicious for IMCC and @entity157 using CTA. RESULTS: On CTA, arterial rim enhancement (ARE) was the initial splitting predictor for assessing the probability of @entity5 being IMCC or @entity157 . Of 43 @entity5 that were classified in a subgroup on CTA based on the presence of ARE, non-intralesional fat, and non-globular shape, 41 (95.3  %) were IMCCs (n   =   29) or CHCs (n   =   12). All 24 @entity5 showing fat on MRI were HCCs. The CTA model demonstrated sensitivity of 84.4  %, specificity of 97.8  %, and accuracy of 92.3  % for discriminating IMCCs and CHCs from HCCs. CONCLUSIONS: We established a simple CTA model for classifying a high-risk group of @entity409 @entity1 with IMCC and @entity157 . This model may be useful for guiding diagnosis for primary @entity96 in @entity1 with @entity409 . KEY POINTS:     Arterial rim enhancement was the initial splitting predictor on CTA.     CTA model achieved high sensitivity, specificity, and accuracy for @entity5 .     This model may be useful for guiding diagnosis of primary @entity96 .

Identification of Imaging Predictors Discriminating Different Primary @entity96 in XXXX with @entity409 on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity18497 :: ('MESH:C073590', 'Chemical') :: ['gadoxetic acid'] @entity96 :: ('MESH:D008113', 'Disease') :: ['liver cancers'] @entity5 :: ('MESH:D009369', 'Disease') :: ['discrimination of tumours', 'tumours'] @entity409 :: ('MESH:D008107', 'Disease') :: ['CLD', 'chronic liver disease'] @entity1419 :: ('MESH:C535533', 'Disease') :: ['intrahepatic cholangiocarcinoma'] @entity157 :: ('MESH:D006528', 'Disease') :: ['combined hepatocellular-cholangiocarcinoma', 'HCC', 'hepatocellular carcinoma', 'CHC']
@entity1 :: (9606,Species) :: ['Patients']
